The human homologue of the Drosophila tumor suppressor lethal (2) tumorous imaginal discs (l(2)tid) gene, hTID1, encodes two proteins derived from alternate mRNA splicing. The splice variants TidL and TidS were previously reported from protein overexpression and dominant-negative mutant protein studies to exhibit opposing biological activities in response to exogenous cytotoxic stimuli. TidL was found to promote apoptosis while TidS suppressed it. To elucidate the physiological function of hTID1, we depleted hTID1 proteins using the technique of RNA interference (RNAi). Here, we show that cells essentially lacking expression of hTID1 proteins are protected from cell death in response to multiple stimuli, including cisplatin, tumor necrosis factor alpha/ cycloheximide and mitomycin C. We also generated stable cell populations depleted of hTID1 proteins by RNAi using DNA vectors. In addition to apoptosis resistance, stable hTID1 knockdown cells exhibited an enhanced ability for anchorage-independent growth, as measured by an increase in soft-agar colony formation. These results suggest that hTID1 functions as an important cell death regulator and raise the interesting possibility that hTID1 could exert tumor suppressor activity.
Introduction
Homozygous deletion of the Drosophila (l(2)tid) gene causes malignant growth of imaginal disc cells and subsequent embryonic lethality (Kurzik-Dumke et al., 1992 , 1995 . During Drosophila development, imaginal discs proliferate and acquire the capacity to differentiate into various adult structures including the head, thorax and genitalia. However in (l(2)tid) mutants, the imaginal discs loose their ability to differentiate. The Drosophila (l(2)tid) gene, which has accordingly been characterized as a tumor suppressor, encodes a 56 kDa protein, TID56, which is processed into a 50 kDa mitochondrial protein (Kurzik-Dumke et al., 1998) .
The human homolog of Drosophila TID56, hTID1, encodes two proteins derived from alternate mRNA splicing. Both hTID1 proteins are synthesized as cytoplasmic preproteins, which get cleaved at their amino-terminus upon entering the mitochondria. The longer protein (TidL) is processed into a 43 kDa mature form, while the shorter, alternatively spliced mature protein (TidS) is 40 kDa (Syken et al., 1999) . TidS mRNA is generated by replacing the carboxyl 33 amino acids of TidL with an exon from within the untranslated region of TidL mRNA, which encodes six amino acids and a stop codon. Both hTID1 proteins predominantly localize to the mitochondrial matrix. The mouse homolog of TID56 encodes similar alternate splice variants (Trentin et al., 2001; Syken et al., 2003) .
The Drosophila, human and mouse Tid proteins are members of the DnaJ family of proteins, which is defined by a highly conserved J domain. DnaJ proteins act as regulatory and specificity factors for the heatshock 70 (Hsp70) family of chaperones with the J domain serving as the Hsp70-binding domain (Cyr et al., 1992; Bukau and Horwich, 1998; Misselwitz et al., 1998; Kelley, 1999; Laufen et al., 1999) . DnaJ/Hsp70 protein complexes are involved in various cellular functions, including protein folding, assembly of multimeric protein complexes, protein degradation, translocation of proteins across membranes (Hendrick et al., 1993; Cyr et al., 1994; Pfanner et al., 1994; Hartl, 1996; Meacham et al., 1999) and even intracellular signaling pathways linked to cell growth and survival.
The two hTID1 proteins were previously observed from protein overexpression studies to exhibit opposing effects on apoptosis in response to exogenous stimuli. Expression of TidL was found to promote apoptosis induced by both the DNA-damaging agent mitomycin c (MMC) and tumor necrosis factor alpha (TNFa)/ cycloheximide (CHX) (Syken et al., 1999) , while TidS expression suppressed it. This demonstrates that the opposed activities of these two splice variants are dependent on their unique carboxyl-terminal tails. In addition, these activities were found to be J domaindependent from overexpression experiments with J domain dominant-negative mutants. Interestingly, the J domain mutation reversed the effects of the wild-type proteins. Overexpressing the J domain mutant of TidL repressed the apoptotic response in a manner similar to TidS, whereas overexpressing the J domain mutant of TidS promoted cell death like TidL. The different activities of the mutant splice variants suggest that each of the wild-type hTID1 proteins have specific activities and substrates. Therefore, TidS is not simply a dominant-negative form of TidL.
hTID1 was originally cloned from a yeast-two hybrid screen using the human papillomavirus E7 oncoprotein as bait (Schilling et al., 1998) . It was reported from subsequent yeast two-hybrid screening to interact with Jak2 (Sarkar et al., 2001) , the herpes simplex virus type 1 origin-binding protein (UL9 protein) (Eom and Lehman, 2002) and the human T-cell leukemia virus type I oncogenic protein Tax . Through its interaction with Jak2, hTID1 was reported to modulate IFNg-mediated transcriptional activity. hTID1 was also observed to repress Tax as well as TNFa and Bcl10-induced NF-kB activation by inhibiting IKKb kinase activity (Cheng et al., 2002) . In addition, a novel gene designated hRFI, for human Ring Finger homologous to X-linked Inhibitor of apoptosis protein, was isolated as an hTID1 interactor by yeast-two hybrid screening (Sasaki et al., 2002) . Mouse TID1 was cloned as a novel p120 GTPase-activating protein (GAP)-binding protein (Trentin et al., 2001) .
Given the opposing activities of the two hTID1 splice variants, it may have been predicted that a lack of hTID1 would have little biological phenotype, since the two splice variants would negate the apoptotic function of each other in response to exogenous stimuli. However, surprisingly we report here that RNA interference (RNAi)-mediated depletion of hTID1 proteins protects cells from death in response to multiple cytotoxic stimuli. The distinct categories of death stimuli tested included death receptor ligands (TNF-related apoptosis-inducing ligand (TRAIL) and TNFa), DNAdamaging agents (cisplatin and MMC), mitochondrial signals (tBID), oxidative stress (H 2 O 2 ) and staurosporine suggesting that hTID1 affects a general and fundamental apoptotic mechanism. Cells stably depleted of hTID1 proteins also showed an increase in soft-agar colony formation. This was not associated with an increased cell growth rate, since these hTID1 knockdown cells actually proliferated slower than control cells. These results suggest that hTID1 functions as an important cell death regulator and raise the interesting possibility that it may exert tumor suppressor activity.
Results

Depletion of TidL by RNAi decreases apoptosis mediated by exogenous stimuli
It was previously shown by overexpression studies of wild-type and J domain dominant-negative mutants that the two hTID1 splice variants have opposing effects on apoptosis in response to exogenous stimuli. Expression of TidL was found to promote apoptosis induced by both the DNA-damaging agent MMC and TNFa/CHX (Syken et al., 1999) , while TidS expression suppressed it. To validate these results by an independent approach, the technique of RNAi was employed to deplete cells of the hTID1 splice variants. As in the previous protein overexpression studies, human U2OS osteosarcoma cells were used for these experiments. We transfected them with double-stranded small inhibitory RNAi (siRNA) oligonucleotides designed to inhibit specifically endogenous expression of TidL and TidS, respectively, or with the corresponding inverted control oligonucleotides (INV). Expression of TidL was dramatically reduced in cells transfected with siTidL as opposed to cells transfected with the corresponding INV control oligonucleotide ( Figure 1a ). This depletion of TidL protein was especially evident by immunoblot analysis at 48 h post-transfection ( Figure 1a ) and persisted until around 6 days post-transfection (data not shown). As shown in Figure 1a , depleting TidL protein had no effect on the level of endogenous TidS protein. Unfortunately, TidS protein expression was largely unaffected by transfection of siTidS ( Figure 1a) . Similar results were obtained using a different siTidS oligonucleotide and also re-transfecting cells with the siTidS oligonucleotides (data not shown). Owing to splicing and the TidSspecific sequence being part of the 3 0 -untranslated region of TidL, we were limited in the design of specific siTidS oligonucleotides to cover the splice junction.
Since these results demonstrate that endogenous TidL protein can be specifically depleted by siRNA, we wanted to determine if siRNA experiments would yield results consistent with the previous finding, that overexpression of TidL enhances the apoptotic response (Syken et al., 1999) . Hence, TidL-depleted cells were treated with the exogenous apoptotic stimuli used in the previous TidL protein overexpression studies (Syken et al., 1999) . U2OS cells transfected with siTidL or the corresponding INV control oligonucleotide or untransfected cells were treated with either the DNA-damaging agent MMC or TNFa/CHX as in the previous protein overexpression studies, or with 10 mg/ml of an additional DNA-damaging agent, cisplatin (or an equal amount of solvent, DMSO, as a control) for 20 h and then evaluated for apoptosis. Depletion of TidL protein expression strongly compromised the ability of U2OS cells to undergo apoptosis in response to TNFa/CHX (Figure 1b) , MMC ( Figure 1c ) and cisplatin (Figure 1d and e). These results indicate that endogenous TidL protein is crucial for U2OS cells to mediate their normal apoptotic response to TNFa/CHX, MMC and also cisplatin. This finding corroborates the results of the previous protein overexpression studies that demonstrated that overexpressed TidL enhanced the apoptotic response of U2OS cells to TNFa/CHX and MMC.
Endogenous mitochondrial expression of hTID1 proteins can be inhibited by RNAi in both U2OS and HeLa cells
The physiological function of the hTID1 proteins is still not completely understood. However, since the technique of RNAi was successfully employed to validate previous work from protein overexpression studies, we set out to further investigate the physiological function of hTID1 by utilizing RNAi to deplete cells of the hTID1 splice variants.
A major fraction of hTID1 proteins have previously been shown by cell fractionation, proteinase protection and digitonin extraction assays, as well as immunoelectron microscopy to reside in the mitochondrial matrix (Syken et al., 1999) . However, at least in some cell types, hTID1 also localizes to the cytoplasm and nucleus (Sarkar et al., 2001) . Similarly, the mouse TID1 proteins may also localize to the mitochondria, cytosol and nucleus, depending on the particular cell type (Trentin et al., 2001) . Furthermore, it was suggested from experiments using a fluorescent hTID1 fusion protein that hTID1 may be translocated to different cellular compartments depending on its association with specific cellular partners, namely, the human T-cell leukemia virus type I oncogenic protein Tax . To detect endogenous hTID1 proteins in U2OS cells, the Tid-specific monoclonal RS-13 antibody (Syken et al., 1999) was utilized for immunofluorescence microscopy (IF) analysis (Figure 2a) . The Tid-specific staining of U2OS cells was found to colocalize with the mitochondrial marker, mitotracker. Identical results were obtained with a second monoclonal (RS-8) and several splice variant-specific polyclonal antibodies (data not shown). Consistent with our earlier biochemical fractionation experiments, these results indicate that the major splice forms of hTID1 mostly colocalize with mitochondria in U2OS cells.
To deplete endogenous hTID1 proteins, U2OS cells were transfected with an siRNA oligonucleotide designed to inhibit expression of both hTID1 protein variants (siTid) (Figure 2b ). IF and immunoblot analyses both revealed that expression of the hTID1 These results were not cell type specific, since similar results were observed in human HeLa cervical carcinoma cells (Figure 2c ). These results show that both endogenous hTID1 proteins are efficiently depleted by siRNA in both U2OS and HeLa cells.
Endogenous hTID1 proteins are necessary for apoptosis induced by various exogenous cytotoxic stimuli in U2OS cells
After demonstrating the validity of the RNAi approach detailed above, it was then utilized in order to gain a better understanding of the physiological function of hTID1. From the previously published work of Syken et al. (1999) , it may have been predicted that a lack of hTID1 would have little biological phenotype, since the two splice variants (with their opposing effects on apoptosis) would negate the apoptotic function of each other in response to exogenous stimuli.
To test initially whether depletion of both hTID1 proteins would have any effect upon apoptosis induction, the exogenous apoptotic stimuli used in the previous protein overexpression studies (Syken et al., 1999) and also in the siTidL depletion experiments in Figure 1b and c were applied to U2OS cells depleted of hTID1 proteins by siRNA. Therefore, U2OS cells transfected with siTid were treated with either the DNA-damaging agent MMC or TNFa/CHX as in Figure 1b and c, and then evaluated by IF for hTID1 expression and also apoptosis (Figure 3a ). U2OS cells depleted of hTID1 proteins were severely impaired in their ability to undergo apoptosis in response to either TNFa/CHX or MMC (Figure 3a and b) . Conversely, cells with wild-type expression of the hTID1 proteins were able to mount an apoptotic response to both TNFa/CHX and MMC. This response included the release of mitochondrial cytochrome c into the cytosol (Figure 3b ). Hence, surprisingly siRNA-mediated depletion of hTID1 proteins protected U2OS cells from death in response to both TNFa/CHX and the DNA-damaging agent MMC. The normal mitochondrial localization of cytochrome c was not affected in hTID1-depleted cells even upon exposure to apoptotic-inducing agents. The fact that cytochrome c was not released into the cytosol in these cells correlates well with them being resistant to apoptosis. The hTID1 proteins were previously found from overexpression studies to affect cytochrome c release from the mitochondria in response to TNFa/CHX (Syken et al., 1999) . Collectively, these results support the model that hTID1 proteins modulate apoptotic signal transduction within the mitochondria.
To add validity to the results obtained so far using transient transfection of siRNA oligonucleotides and to enable conductance of longer-term hTID1 depletion assays, a DNA vector-based RNAi approach was utilized to create stable hTID1 knockdown U2OS cell lines. This technology allows the synthesis of siRNAs from DNA templates in vivo to inhibit endogenous gene expression (Sui et al., 2002) . U2OS cells were stably transfected with a Bluescript-based plasmid containing a DNA template for the synthesis of an siRNA oligonucleotide designed to inhibit specifically endogenous expression of both hTID1 protein variants, under the control of the human U6 promoter (pBS/U6/hTID1) or with empty pBS/U6 vector alone. The RNA encoded by this expression plasmid is predicted to self-anneal, forming a small hairpin double-stranded RNA (Sui et al., 2002) . Importantly, the hTID1 sequence encoded by this RNAi plasmid is distinct from the region targeted by the siTid oligonucleotide that was utilized for transient hTID1 knockdown experiments, as discussed above. All U2OS cells were cotransfected with a selectable marker, in this case the neomycin resistance gene at a ratio of 1 : 10 (selection marker versus effector plasmids), to allow selection of transformants. Neomycin-resistant clones were selected and cells depleted of endogenous hTID1 proteins were identified by IF and immunoblot analyses (Figure 3c ). Expression of the Cells transfected with siTid were treated with 10 ng/ml TNFa and 30 mg/ml CHX for 5 h, or 20 mg/ml MMC for 24 h and then analysed by IF for hTID1 expression as well as apoptosis. Apoptosis was determined by the assessment of nuclear morphology using Hoechst 33258 DNA staining. Apoptotic cells were counted as having either wild-type expression of hTID1 (wt) or siRNA-mediated depletion of hTID1 proteins (siTid). The graph shown is from the results of at least three independent experiments. (b) siRNAmediated depletion of hTID1 proteins from U2OS cells prevents the cells normal TNFa/CHX and MMC-induced apoptotic response including the release of mitochondrial cytochrome c. U2OS cells transfected with siTid or with the corresponding INVs were treated with 10 ng/ml TNFa and 30 mg/ml CHX for 5 h, or 20 mg/ml MMC for 24 h. The cells were analysed by IF after double staining with TidS specific polyclonal antiserum (counterstained with a rhodamine red-coupled secondary antibody) and anti-cytochrome c (detected using a fluorescein-labeled secondary antibody, green). hTID1 expression was detected using the TidS-specific polyclonal antibody so that different species of secondary antibodies were used. Nuclei were visualized with Hoechst 33258 DNA dye. The scale bar indicates 10 mm. (c) U2OS cell lines stably depleted of endogenous hTID1 proteins by DNA vector-based RNAi. IF (upper panel) and immunoblot (lower panels) analyses of hTID1 proteins in U2OS cells stably transfected with a Bluescript-based vector containing a DNA template for the synthesis of an siRNA oligonucleotide complementary to a region conserved between both the TidL and TidS genes under the control of the human U6 promoter (pBS/U6/hTID1) (represented by clone 4.15). As a control, U2OS cells were stably transfected with empty pBS/U6 vector alone (represented by clone VA-4). hTID1 staining was detected using a rhodamine red-labeled secondary antibody. Nuclei were visualized with Hoechst 33258 DNA dye. The scale bar indicates 10 mm. Actin is used as a loading control (lower immunoblot panel). (d and e) U2OS clones stably depleted of hTID1 proteins by DNA vector-based RNAi are drastically impaired in eliciting their normal apoptotic response to MMC, TRAIL/CHX, staurosporine (STS) and tBID. Cells stably transfected with the RNAi plasmid pBS/U6/hTID1 (represented here by clone 4.15) or with empty pBS/U6 vector alone (represented by clone VA-4) were treated with 1 mM staurosporine for 4 h (d and e), or with 10 ng/ml TRAIL and 30 mg/ml CHX for 20 h, or 20 mg/ml MMC for 24 h, or transiently transfected with pcDNA3 vector encoding tBID (d). After treatment, the cells were analysed for apoptosis that was determined by the assessment of nuclear morphology using Hoechst 33258 DNA staining. Apoptotic nuclei were counted as a percentage of total nuclei with the data shown representing at least three independent experiments. The scale bar indicates 10 mm hTID1 proteins was drastically reduced in cells stably transfected with the pBS/U6/hTID1 plasmid (represented by clone 4.15 in Figure 3c ) compared to clones stably transfected with empty pBS/U6 vector alone (represented by clone VA-4 in Figure 3c ). These results show that both endogenous hTID1 proteins can be stably depleted in U2OS cells using a DNA vector-based RNAi approach. Next, these U2OS clones stably transfected with the pBS/U6/hTID1 RNAi plasmid or with empty pBS/U6 vector alone were treated with MMC as carried out previously (in Figures 1c, 3a and b), or with 1 mM staurosporine for 4 h, or 10 ng/ml TRAIL and 30 mg/ml CHX for 20 h, or transiently transfected with pcDNA3 vector encoding tBID and then evaluated for apoptosis (Figure 3d and e). Consistent with the transient siRNA results, U2OS cells stably depleted of hTID1 proteins by RNAi were markedly resistant to the apoptotic stimuli tested. These results demonstrate that the hTID1 proteins are important mediators of TNFa/CHX, TRAIL/CHX, MMC, staurosporine and tBID-induced apoptosis in U2OS cells.
Endogenous hTID1 proteins are necessary for apoptosis induced by various exogenous cytotoxic stimuli in HeLa cells
Since depletion of both hTID1 proteins was found to protect the human U2OS osteosarcoma cell line from death in response to multiple cytotoxic stimuli, it was next determined whether similar results may be observed in a different cell line. To address this question, the apoptosis induction experiments were repeated in the human cervical carcinoma cell line HeLa, depleted of endogenous hTID1 proteins by the siRNA oligonucleotide, siTid (see Figure 2c) . Therefore, HeLa cells transfected with siTid were treated with 2 mM H 2 O 2 for 3 h as well as with the following cytotoxic stimuli utilized previously with U2OS cells: cisplatin, MMC, TNFa/CHX, TRAIL/CHX, tBID and staurosporine. The HeLa cells were then evaluated by IF for hTID1 expression and apoptosis (Figure 4a ). Depletion of endogenous hTID1 proteins severely compromised the ability of HeLa cells to undergo apoptosis in response to TNFa/CHX, TRAIL/CHX, staurosporine, cisplatin, MMC, H 2 O 2 and tBID (Figure 4a and b) . These results obtained from HeLa cells depleted of hTID1 proteins by siRNA recapitulate those obtained in U2OS cells. This indicates that the surprising finding that decreased levels of endogenous hTID1 proteins protect from death mediated by exogenous stimuli is not limited to only one cell type. Collectively, these results demonstrate that RNAi-mediated depletion of endogenous hTID1
Figure 4 (a and b) HeLa cells depleted of hTID1 proteins by siRNA are unable to elicit their normal apoptotic response to TRAIL/CHX, TNFa/CHX, staurosporine, cisplatin, MMC, H 2 O 2 or tBID. Cells transfected with siTid or with the corresponding inverted control oligonucleotide (INV) as shown in (b) were treated with 10 ng/ml of either TNFa or TRAIL and 30 mg/ml CHX for 5 or 20 h, respectively, or with 1 mM staurosporine for 4 h, or 10 mg/ml cisplatin for 20 h, or 20 mg/ml MMC for 24 h, or 2 mM H 2 O 2 for 3 h, or transiently transfected with pcDNA3 vector encoding tBID (or with empty pcDNA3, vector alone, as a control). After treatment, the cells were analysed by IF for hTID1 expression using the Tid monoclonal RS-13 (counterstained with a rhodamine red-labeled secondary antibody), as well as apoptosis, which was determined by the assessment of nuclear morphology using Hoechst 33258 DNA staining. Apoptotic cells were counted as having either wildtype expression of hTID1 (wt) or siRNA-mediated depletion of both hTID1 proteins (siTid). The data shown represent three independent experiments. The scale bar indicates 10 mm proteins protects cells from death in response to multiple cytotoxic stimuli. This supports the notion that the hTID1 proteins are important mediators of the normal apoptotic response to various exogenous stimuli.
Stable depletion of endogenous hTID1 proteins enhances the anchorage-independent growth of U2OS cells
As these results suggest that the hTID1 proteins are important mediators of apoptosis to multiple exogenous stimuli, they raised the question of whether the hTID1 proteins could also play a role in cellular transformation. To investigate this possibility, we analysed the effect of stably depleting both hTID1 proteins, by DNA vector-based RNAi (see Figure 3c) , upon the transformed phenotype of U2OS cells. Hence, cells stably transfected with the pBS/U6/hTID1 RNAi plasmid or with empty pBS/U6 vector alone were plated in 0.3% soft agar and the colony number was counted after 2 weeks as a measure of anchorage-independent growth. U2OS clones stably depleted of endogenous hTID1 proteins formed approximately 40% more colonies in soft agar as shown in Figure 5a and b with the representative clone 4.15, than U2OS cells stably transfected with the empty pBS/U6 vector alone (represented with clone VA-4 in Figure 5a and b). These results, which have been reproduced with two independent clones, demonstrate that stable depletion of endogenous hTID1 proteins enhances the anchorageindependent growth of U2OS cells.
Stable depletion of endogenous hTID1 proteins does not induce hyperproliferation of U2OS cells
Since depletion of endogenous hTID1 proteins was found to increase the anchorage-independent growth of U2OS cells, as measured by enhanced colony formation in soft agar, the possibility that this was a consequence of increased cell proliferation was next addressed. To analyse this possibility, the effect of stably depleting both hTID1 proteins, by DNA vector-based RNAi (see Figure 3c ), upon the proliferation of U2OS cells was determined. Therefore, U2OS clones stably transfected with the RNAi plasmid pBS/U6/hTID1 or with empty pBS/U6 vector alone or untransfected cells were stained with the cell proliferation marker BrdU and analysed by IF. Cells undergoing DNA synthesis incorporated BrdU into their DNA. Fewer cells stably depleted of endogenous hTID1 proteins incorporated BrdU as shown in Figure 6a and b with the representative clone 4.15 compared to U2OS cells stably transfected with the empty pBS/U6 vector alone (represented with clone VA-4 in Figure 6a and b) or with untransfected U2OS cells (Figure 6a ). These results demonstrate that stable depletion of hTID1 proteins decreases the proliferation rate of U2OS cells as measured by BrdU incorporation.
To validate the results described above from BrdU incorporation assays, further proliferation experiments were performed counting cell numbers. U2OS cells stably transfected with the pBS/U6/hTID1 RNAi plasmid or with empty pBS/U6 vector alone were cultured for up to 4 days and the cell number was counted every 24 h (Figure 6c and d) . Clones stably depleted of endogenous hTID1 proteins grew slower as shown in Figure 6c with the representative clone 4.15, than U2OS cells stably transfected with the empty pBS/ U6 vector alone (represented with clone VA-4 in Figure 6c ). Furthermore, U2OS cells stably depleted of both hTID1 proteins were unable to proliferate in low serum or a complete absence of serum (Figure 6d ). These results demonstrate that stable depletion of endogenous hTID1 proteins decreases the proliferation rate of U2OS cells as determined by cell growth in culture. As expected, these results replicate the results obtained from BrdU incorporation assays. Collectively, these results demonstrate that U2OS cells stably depleted of endogenous hTID1 proteins by a DNA vector-based RNAi approach are not hyperproliferative, but rather proliferate slower than cells stably transfected with the vector alone control. Therefore, these results suggest that the enhanced anchorageindependent growth of U2OS cells stably depleted of endogenous hTID1 proteins is not due to hyperproliferation. 
Discussion
The two hTID1 protein variants were previously found from protein overexpression studies with wild-type and J domain dominant-negative mutants to exert opposing biological effects. The TidL protein was observed to promote apoptosis, while the alternatively spliced TidS form suppressed the apoptotic response to TNFa/CHX and MMC (Syken et al., 1999) . Since little is known concerning the actual function of the hTID1 proteins in vivo, it may have been predicted then that a lack of hTID1 would have little biological phenotype since the .15) or with empty pBS/U6 vector alone (represented by clone VA-4) were cultured for up to 4 days in medium containing 5%, 2.5% or 0% FBS two splice variants would negate the apoptotic function of each other in response to exogenous stimuli. Here, we report that depletion of endogenous hTID1 proteins strongly protects cells from death mediated by multiple cytotoxic stimuli.
We show that endogenous TidL protein can be specifically depleted by siRNA (Figure 1a ) and that this depletion severely compromises the ability of U2OS cells to induce apoptosis in response to TNFa/CHX, MMC or cisplatin (Figure 1b-e) . Therefore, TidL appears necessary for U2OS cells to mount their normal apoptotic response to TNFa/CHX, MMC or cisplatin. These results are consistent with the finding that overexpression of the TidL protein enhances the apoptotic response of U2OS cells to TNFa/CHX or MMC (Syken et al., 1999) . Hence, we successfully utilized the technique of RNAi to validate findings from previous protein overexpression experiments.
In contrast, we did not succeed in substantially depleting endogenous TidS protein from U2OS cells by siRNA (Figure 1a ). This was despite utilizing two different siRNA oligonucleotides and also retransfecting U2OS cells with the oligonucleotides (data not shown). Although U2OS cells (and many other cell types) have higher endogenous levels of TidS compared to TidL protein levels, this does not account for the inability of the siRNA oligonucleotides to degrade TidS mRNA and silence expression of the TidS gene, since TidS was effectively depleted when both forms were targeted. Rather, it is likely that the siRNA oligonucleotides were unable to silence the TidS gene due to the limited sequence available for specific targeting of the TidS gene. The only region specific to the TidS gene is the splice junction at the carboxyl-terminus where 33 amino acids of TidL mRNA are replaced with an exon from the 3 0 -untranslated region of TidL mRNA which encodes six amino acids and a stop codon.
We successfully employed siRNA to deplete endogenous hTID1 proteins from U2OS and also HeLa cells (Figure 2b and c) . Surprisingly, depletion of both hTID1 proteins drastically impaired the normal apoptotic response of these cells to various cytotoxic stimuli including TNFa/CHX, MMC, cisplatin, TRAIL/CHX, staurosporine, H 2 O 2 and tBID (Figures 3a and b, 4a and  b) . This surprising finding that depletion of endogenous hTID1 proteins protects from death mediated by exogenous stimuli was not cell type specific, since it was observed in both U2OS and HeLa cells.
To further validate these results obtained using transient transfection of siRNA oligonucleotides, similar experiments were performed in U2OS cell lines stably depleted of both endogenous hTID1 proteins by a DNA vector-based RNAi approach (Figure 3c ). Consistent with our previous findings, U2OS clones stably depleted of hTID1 proteins were markedly compromised in their ability to undergo apoptosis in response to MMC, TRAIL/CHX, staurosporine and tBID (Figure 3d and e). This result further illustrates the importance of the hTID1 proteins as an apoptotic modulator in response to multiple stimuli. Furthermore, the hTID1 sequence targeted by the siTid oligonucleotide was different to the hTID1 region encoded by the pBS/U6/hTID1 RNAi plasmid. Using two independent oligonucleotide sequences to target the hTID1 gene controls for specificity of the observed hTID1 silencing effect.
The two oligonucleotide sequences also used map to different domains of hTID1. The pBS/U6/hTID1 RNAi plasmid encodes a region within the glycine/phenylalanine-rich domain of hTID1, while the siTid oligonucleotide targeted sequence is within the hTID1 J domain. Inhibiting endogenous expression of hTID1 proteins by targeting a sequence within the J domain with an siRNA oligonucleotide will deplete all hTID1 J domaincontaining transcripts. Previous overexpression experiments with TidL and TidS J domain dominant-negative mutants showed the apoptotic activities of the two hTID1 splice variants to be J domain-dependent (Syken et al., 1999 ). An additional Tid splice variant has been reported (Trentin et al., 2001; Yin and Rozakis-Adcock, 2001 ). It appears to represent a low abundance mRNA species that may encode a highly unstable protein. Sarkar et al. (2001) also detected an additional hTID1-related band by immunoblot analysis, which they suggest may represent an additional splice variant of hTID1, although it was not detected in the majority of cell lines they examined. Hence, even if additional J domain-containing hTID1 splice variants that are not recognized by the Tid-specific RS-13 monoclonal antibody (Syken et al., 1999) would exist in U2OS and HeLa cell lines, they would be depleted by our siTid oligonucleotide.
Collectively, these results demonstrate that RNAimediated depletion (both transient and stable) of endogenous hTID1 proteins protects cells from death in response to multiple cytotoxic stimuli. This supports the notion that the hTID1 proteins are an important and potentially essential mediator of the normal apoptotic response to various exogenous stimuli. It was proposed from previous protein overexpression studies (Syken et al., 1999) that the two hTID1 protein variants (with their opposing apoptotic functions) modulate apoptotic signal transduction or apoptotic effector structures within the mitochondria. Our experiments show that depletion of both endogenous hTID1 proteins protects from death in response to various cytotoxic stimuli. Although it is surprising that depletion of the hTID1 proteins has such a dramatic phenotype, it fits with the proposed model that this occurs in response to stimuli that mediate apoptosis through the mitochondria such as the truncated proapoptotic Bcl-2 family member, BID (tBID). Cleaved BID (tBID) translocates from the cytosol to mitochondria during apoptosis induction (Wang et al., 1996; Luo et al., 1998; Gross et al., 1999) and interacts with the proapoptotic proteins Bax and Bak (Desagher et al., 1999; Eskes et al., 2000; Wei et al., 2000 Wei et al., , 2001 , mediating mitochondrial damage including cytochrome c release. BID can be cleaved by active caspase-8, making BID a protein that can connect activation of the death receptor pathway to activation of the mitochondrial pathway (Li et al., 1998) . Our results demonstrate that depletion of both hTID1 proteins protects cells from apoptosis mediated by the death receptor ligands TNFa and TRAIL, in conjunction with the translation inhibitor CHX. TRAIL is a member of the TNF family of cytokines. TNFa is a cytokine produced by the immune system in response to virus infection (reviewed by Benedict et al., 2003) . It can mediate death signaling through TNFa receptor 1 (Tartaglia et al., 1993; Kondo and Sauder, 1997; reviewed by Aggarwal, 2003) by the recruitment and activation of caspase-8 that can induce the generation of tBID. TNFa-mediated death signaling induces the interaction and oligomerization of Bax and Bak and the release of the mitochondrial proteins cytochrome c and also Smac/DIABLO (Du et al., 2000; Perez and White, 2000; Verhagen et al., 2000; Sundararajan et al., 2001; Degenhardt et al., 2002) . We found that depletion of endogenous hTID1 proteins also protects cells from death mediated by the DNA-damaging agents MMC and cisplatin as well as the classic apoptotic stimulus, staurosporine. Our results also demonstrate that depletion of both hTID1 proteins protects cells from death mediated by the oxidant H 2 O 2 . H 2 O 2 is a Ca 2 þ -dependent stimulus of oxidative stress. It can induce cell death with apoptotic morphology, although it requires Bax or Bak to do so (Hockenbery et al., 1993; Maroto and Perez-Polo, 1997; Scorrano et al., 2003) . Although endogenous Bax and Bak localize predominantly to the mitochondrial outer membrane, they are also found at the endoplasmic reticulum (ER) (Gajkowska et al., 2001; Nutt et al., 2002b; Scorrano et al., 2003; Zong et al., 2003) . Therefore, a requirement for Bax or Bak does not necessarily indicate involvement of the mitochondria. Bax and Bak at the mitochondria are a requisite for 'BH3-only' proteins such as tBID (discussed above); however, regulation of ER Ca 2 þ by Bax and Bak is required for oxidative stimuli such as H 2 O 2 (Scorrano et al., 2003; reviewed by Finkel and Holbrook, 2000) . Therefore, cell death mediated by H 2 O 2 is not dependent on signaling through the mitochondria. Alternatively, the intrinsic cell death signals initiated by staurosporine are influenced by control points at both the mitochondria and the ER (Nutt et al., 2002a; Scorrano et al., 2003) . Therefore, although it is surprising that depletion of the mostly mitochondrial hTID1 proteins has such a dramatic phenotype, it is even more surprising that this occurs in response to stimuli that do not mediate apoptosis through the mitochondria, such as H 2 O 2 , which mediates its apoptotic effect through the ER or staurosporine, which signals via both the ER and mitochondria.
We have shown that depletion of both endogenous hTID1 proteins protects from cell death mediated by various categories of stimuli. This suggests that the hTID1 proteins are affecting some generalized apoptotic mechanism. These results are consistent with our previous work (Syken et al., 2003) in suggesting that the hTID1 proteins may also affect nonmitochondrial aspects of apoptosis. Previously, we demonstrated that TidS is selectively induced in activated murine Th2 cells. Th2 cells are significantly less sensitive to apoptosis induced by stimulation through the T-cell receptor than the other subset of helper T cells, Th1. This apoptotic process is known as activation-induced cell death (AICD). Interestingly, interfering with TidS function in Th2 cells, by overexpressing the J domain mutant of TidS, abrogated their resistance to AICD. It is thought that the mitochondria do not play a major role in the regulation of AICD. Therefore, this previous work suggested that TidS may affect AICD through nonmitochondrial mechanisms. Hence, these results strongly support the model that hTID1 proteins can act through nonmitochondrial pathways to regulate cell death. However, the precise mechanisms of this function remain to be elucidated. hTID1 has recently been shown to interact with several proteins that may contribute to this function. The hTID1 proteins have been reported to interact with nonmitochondrial viral proteins, including the HTLV-1 oncoprotein Tax that induces marked cytoplasmic relocalization of hTID1 . Through its interaction with the protein tyrosine kinase Jak2 and the IFNg receptor subunit IFNgR2, hTID1 can modulate IFNg-mediated transcriptional activation (Sarkar et al., 2001) . Jak2 plays an important role in multiple cytokine signal transduction pathways. The hTID1 proteins can also modulate NF-kB signaling by suppressing IKKb kinase activity (Cheng et al., 2002) . The NF-kB transcription factor is an important modulator of apoptosis, including TNFa-mediated apoptosis. An additional attractive hTID1 interactor is the hRFI protein, which contains a Ring Finger with homology to X-linked Inhibitor of apoptosis protein, and ectopic hRFI expression can interfere with TNFainduced apoptosis of HeLa cells (Sasaki et al., 2002) .
The results presented here demonstrate that the hTID1 proteins are important mediators of apoptosis to multiple exogenous stimuli, suggesting that they may also play a potential role in cellular transformation. Investigation of this question was possible after generation of the U2OS cell lines stably depleted of both endogenous hTID1 proteins, since they allowed conductance of longer-term hTID1 depletion assays. Stable depletion of endogenous hTID1 proteins increases the anchorage-independent growth of U2OS cells as measured by colony formation in soft agar (Figure 5a and b). The ability of U2OS clones stably depleted of hTID1 proteins to form more colonies in soft agar than cells stably transfected with empty vector alone is not due to hyperproliferation of the stable hTID1 knockdown cell lines. Here we show by BrdU incorporation (Figure 6a and b) and also cell growth in culture (Figure 6c ) that U2OS cells stably depleted of hTID1 proteins actually proliferate slower than U2OS cells stably transfected with the empty vector alone. Therefore, the hTID1 proteins have some biological activities consistent with a tumor suppressor, namely, that depletion of endogenous hTID1 proteins leads to the transformation of U2OS cells based on anchorage-independent growth. These results validate previous findings that overexpressing hTID1 inhibited the transforming phenotype of two human lung adenocarcinoma cell lines, as measured by a reduced ability for colony formation in soft agar ). Furthermore, expression of endogenous hTID1 was found altered in human basal cell carcinomas as compared to normal skin (Canamasas et al., 2003) . This finding implicates a correlation between the loss of hTID1 expression and loss of differentiation capacity of the neoplastic cells, similar to that found in the Drosophila tumor model. However, depletion of the hTID1 proteins does not lead to serum-independent growth (Figure 6d ), another characteristic of cellular transformation. Since depletion of the hTID1 proteins decreases cell proliferation (although not anchorageindependent growth), hTID1 protein inhibitors may have potential antimitogenic effects. Interestingly, the promoter sequence of the hTID1 gene has been analysed and shown to contain consensus-binding sites for various transcription factors implicated in cell growth and survival responses including AP-1, PEA3, E2F and NFkB ). Consistent with depletion of the hTID1 proteins affecting the transformed phenotype of U2OS cells is our finding that depletion of the hTID1 proteins protects cells from death induced by multiple cytotoxic stimuli.
In summary, we have shown using transient transfection of siRNA oligonucleotides and also stable transfection of a DNA vector-based RNAi approach that the hTID1 proteins are important cell death regulators that may also exert tumor suppressor activity. Our studies provide a valuable system and framework to decipher the mechanisms employed by the hTID1 proteins.
Materials and methods
Cell culture
The human U2OS osteosarcoma and the HeLa cervical carcinoma cell lines were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin. Stable U2OS cell lines were cultured under constant selection with 500 mg/ml of G418 (Research Products International, Mt Prospect, IL, USA).
RNAi
To deplete endogenous hTID1 proteins by RNAi, siRNA oligonucleotides (Dharmacon Research, Lafayette, CO, USA) were designed according to the manufacturer's recommendations with sequence homology to a region conserved between both the TidL and TidS genes. The sequence used, 5 0 -gauuauuaucagauauuag dT dT-3 0 , was 273 nucleotides from the start codon, which is within the region encoding the J domain of hTID1 (Schilling et al., 1998) . siRNA oligonucleotides were also designed with sequence homology specific to only the TidL or the TidS gene. The sequences used were 5 0 -cuuaagaaaauguuuaccu dT dT-3 0 for the TidL complementary strand and 5 0 -gguaaaagauccacuggaa dT dT-3 0 for the TidS complementary strand. Corresponding inverted oligonucleotides were synthesized as controls. siRNA duplexes were prepared by annealing sense and antisense RNA oligonucleotides in annealing buffer (100 mM potassium acetate, 30 mM HEPES-KOH pH 7.4, 2 mM magnesium acetate) for 1 min at 901C followed by 60 min at 371C. U2OS or HeLa cells were transiently transfected with the resulting 20 mM annealed siRNA oligonucleotide duplexes using Oligofectamine (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Prior to transfection, 10 5 cells were seeded in wells on 12-well tissue culture plates in 1 ml of medium containing no FBS. The cells were allowed to adhere to either the wells or, for eventual IF analysis, glass coverslips in the wells by overnight incubation at 371C and 5% CO 2 . Then, 6 ml of siRNA oligonucleotide duplex was mixed with 100 ml of Opti-MEM medium (GIBCO, Invitrogen) and in a separate tube, 6 ml of Oligofectamine was added to 24 ml of Opti-MEM. After 10 min incubation at room temperature, the two solutions were mixed and then incubated for an additional 25 min. The resulting solution was adjusted to a final volume of 200 ml with Opti-MEM and then added evenly to subconfluent cells in a well on a 12-well plate. Cells were incubated with the transfection mixture at 371C and 5% CO 2 for 48 h prior to treatment with apoptotic mediators. Unless stated otherwise, cells were harvested 72 h post-transfection for IF or immunoblot analyses. These methods were utilized in all experiments to ascertain depletion of the hTID1 proteins.
Construction of stable gene silencing cell lines
U2OS cells were stably transfected using the calcium phosphate method with an RNA polymerase III, U6 promoter-based DNA vector to synthesize siRNA in the cell (pBS/U6, kindly provided by Y Shi; Harvard Medical School, Boston, MA, USA). The vector was engineered to encode an siRNA product with sequence homology to the hTID1 gene (Sui et al., 2002) . The strategy involved subcloning an inverted repeat, separated by a six nucleotide spacer, into the parental plasmid at the ApaI site to generate the RNAi plasmid (pBS/ U6/hTID1). The sequence used 5 0 -ggggtcaacaaggagttcacc-3 0 for the RNAi construct was 663 nucleotides from the start codon of the hTID1 gene. This is within the region encoding the glycine/phenylalanine-rich domain of hTID1 (Schilling et al., 1998) and is distinct from the sequences of the synthetic siRNA oligonucleotides. At 1 day prior to transfection, 6 Â 10 5 U2OS cells were seeded in a 6-cm tissue culture plate with 5 ml of media. Briefly, 10 mg of total plasmid DNA and 1 mg of CMV plasmid DNA encoding the neomycin resistance gene, pCMV-BamHI-Neo plasmid (as a selection marker for transfectants), were mixed with 250 ml of 2 Â BES and 250 ml of 0.25 M CaCl 2 . After 20 min incubation at room temperature, the solution was evenly added to a subconfluent 6-cm plate of U2OS cells. The cells were left in the transfection mixture for 16 h at 371C and 5% CO 2 , then washed in phosphate-buffered saline (PBS) and returned to fresh medium. After 24 h, the cells were passaged into media supplemented with 500 mg/ml of G418 for selection of transfectants. Cells were selected for at least 12 days prior to cloning. Depletion of the hTID1 proteins was ascertained by IF and/or immunoblot analysis in each experiment.
Western blotting
Cells were trypsinized, washed in PBS and lysed in 1% Nonidet P-40, 150 mM NaCl, 50 mM Tris-HCl (pH 8.0) buffer supplemented with protease inhibitors (1 mg/ml aprotinin and leupeptin, 0.01% phenylmethylsulfonyl fluoride) for 30 min at 41C. After centrifugation, protein concentrations were determined using the Bradford method (Bio-Rad, Hercules, CA, USA). Total protein lysate (100 or 30 mg for large or small gels, respectively) samples were subjected to 12.5% SDS-polyacrylamide gel electrophoresis (PAGE) and then transferred onto polyvinylidene difluoride membranes (PolyScreen; PerkinElmer Life Sciences, Boston, MA, USA) using an electroblotter (Bio-Rad) and standard protocols. The following antibodies were used: Tid monoclonal RS-13 (Syken et al., 1999) , which recognizes an epitope conserved between the short and long splice forms of hTID1, TidL-and TidS-specific polyclonals (kindly provided by C Suzuki; New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA) and actin (CHEMICON, Temecula, CA, USA). Proteins were detected using enhanced chemiluminescence (Perkin-Elmer Life Sciences) and X-ray film or by digital acquisition using a Bio-Rad Fluor-S Max Multi-imager.
Apoptosis induction
All cells were seeded in 12-well tissue culture plates containing glass coverslips. Stable U2OS cell clones were seeded at 3 Â 10 5 cells/ml 24 h prior to apoptosis induction. U2OS or HeLa cells transiently transfected with siRNA oligonucleotides were treated 48 h post-transfection.
Cells were treated with 10 ng/ml of either TNFa (R&D Systems, Minneapolis, MN, USA) or TRAIL (Alexis, San Diego, CA, USA) and 30 mg/ml of CHX (Sigma, St Louis, MO, USA) for 5 or 20 h, respectively. Staurosporine (Sigma) treatment was for 4 h at a final concentration of 10 mM, while cells were exposed to 2 mM of H 2 O 2 (Fisher Scientific, Fair Lawn, NJ, USA) for 3 h. Alternatively, cells were treated with 20 mg/ml of MMC (Sigma) for 24 h or for 20 h with 1 mg/ml of cisplatin (Sigma) or an equal volume of solvent, DMSO (Mallinckrodt Baker, Paris, KY, USA), as a control.
Cells were transiently transfected with pcDNA3 vector encoding tBID (kindly provided by S Korsmeyer; DanaFarber Cancer Institute, Boston, MA, USA) or with empty pcDNA3 vector alone using the calcium phosphate technique, described above. Briefly, 10 mg of total plasmid DNA was cotransfected with 1 mg of green fluorescent protein DNA (EGFP-C1 plasmid; BD Clontech, Palo Alto, CA, USA) as a marker of transfectants. 167 ml of the transfection solution was evenly added to subconfluent U2OS or HeLa cells in wells on 12-well plates. The cells were left in the transfection mixture for 16 h at 371C and 5% CO 2 , then washed in PBS and returned to fresh medium for 2 h. Cells were scored as apoptotic based on nuclear morphology using the DNA dye bisbenzimide (Hoechst 33258; Sigma). Apoptotic cells were quantified as a percentage of total nuclei and at least 600 cells were counted per sample.
Immunofluorescence microscopy
Cells were seeded at 3 Â 10 5 /ml in 12-well plates and allowed to adhere overnight at 371C and 5% CO 2 to glass coverslips in the wells. Adherent cells were washed twice in PBS to remove the media and then fixed in 4% paraformaldehyde, PBS for 15 min. All of the incubations were performed at room temperature unless stated otherwise. After washing with PBS, the cells were permeabilized for 10 min in 1% Triton X-100, PBS and following further washing in PBS, blocked in normal donkey serum (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) diluted 1 : 10 in H 2 O for 10 min. Cells were once again rinsed in PBS and then incubated overnight at 41C with Tid monoclonal antibody RS-13 (1 : 10 in PBS). Coverslips were washed with PBS and then incubated for 2 h at 371C with rhodamine red-or fluorescein-conjugated donkey anti-mouse secondary antibodies diluted 1 : 200 in PBS (Jackson ImmunoResearch Laboratories). If the cells were also stained with mitrotracker, a fluorescein-labeled secondary antibody was utilized. Such cells were initially incubated with mitotracker (Molecular Probes, Eugene, OR, USA) diluted 1 : 2000 in PBS for 10 min at 371C. For simultaneous detection of Tid and cytochrome c, hTID1 expression was detected using the TidS-specific polyclonal antibody (diluted 1 : 2500 in PBS) so that different species of secondary antibodies would be used. Cells were stained for Tid and counterstained with a rhodamine red-labeled anti-rabbit secondary antibody (1 : 1000 in PBS; Jackson ImmunoResearch Laboratories) as described above. Subsequently they were incubated with the cytochrome c monoclonal antibody 6H2.B4 (1 : 60 in PBS; BD PharMingen, Los Angeles, CA, USA), which was detected with a fluorescein-conjugated anti-mouse secondary antibody. All cells were stained with 1 mg/ml of Hoechst 33258 for 5 min to allow visualization of nuclei.
Soft-agar assays
Anchorage-independent growth was assayed by colony formation in soft agar. Triplicate samples of 1 Â 10 3 or 0.4 Â 10 3 cells were suspended in 2 ml of appropriate medium containing 0.3% Bacto agar and 20% FBS and plated in a well on a sixwell tissue culture plate. After the agar was allowed to set at room temperature for 1 h, it was overlaid with medium. The cells were incubated in the agar at 371C and 5% CO 2 for 2 weeks before the number of colonies in each well was counted.
Brdu incorporation assay
Proliferating cells were visualized using the BrdU labeling and detection kit I (Roche, Indianapolis, IN, USA) according to the manufacturer's instructions. Briefly, cells grown to about 50% confluency on coverslips inside wells on 12-well tissue culture plates were incubated in BrdU labeling medium at 371C and 5% CO 2 for 45 min. After washing, the cells were ethanol fixed at À201C for 20 min, washed again and then incubated with anti-BrdU monoclonal antibody for 30 min at 371C. Fluorescein-conjugated anti-mouse immunoglobulin was then added for 30 min at 371C. Cells were counterstained with DAPI and coverslips were mounted using Vectashield mounting medium (Vector Laboratories, Burlingame, CA, USA). Cells that were undergoing DNA synthesis and hence had incorporated BrdU into their DNA were visualized by IF and counted as a percentage of total cells.
Detection of cell proliferation
Duplicate samples of 3 Â 10 5 cells were seeded in a well on a 12-well tissue culture plate and cultured for up to 4 days. After counting the cell number every 24 h, the cells were replated in fresh medium. The cells' ability to proliferate in the absence of serum was analysed by repeating the above experiment in medium containing 5%, 2.5% or 0% FBS.
Abbreviations AICD, activation-induced cell death; CHX, cycloheximide; ER, endoplasmic reticulum; FBS, fetal bovine serum; IF, immunofluorescence microscopy; MMC, mitomycin c; RNAi, RNA interference; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline; siRNA, double-stranded small inhibitory RNAi; TNFa, tumor necrosis factor alpha; TRAIL, TNF-related apoptosis-inducing ligand.
